DRAP Invites Comments on Draft Amendments to the Drugs (Research) Rules, 1978
DRAP has published proposed amendments to the Drugs (Research) Rules, 1978, the rules that govern clinical research on medicines in Pakistan, and has asked stakeholders for their views.
Comments and suggestions must reach DRAP within seven days of the notification's publication on 11 September 2026. They can be sent by post or by email to the authority's Director Legal.
Key points
- The draft amendments concern the Drugs (Research) Rules, 1978.
- Stakeholder comments are open for seven days from publication (notice dated 11 September 2026).
- Feedback can be submitted by post or by email to DRAP's Director Legal.
- The draft notification is available to download from DRAP.
What it means for you
Investigators, research ethics committees and sponsors running clinical trials in Pakistan should review the draft, as changes to these rules may affect how studies are approved and conducted.
Notification of Draft Amendments in the Drugs (Research) Rules, 1978
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.